Oxidative stress in NSC-741909-induced apoptosis of cancer cells

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Wei, Xiaoli ^a,b   Guo, Wei ^b   Wu, Shuhong ^b   Wang, Li ^b   Huang, Peng ^b   Liu, Jinsong ^b   Fang, Bingliang ^b  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BAICALEIN; CAFFEIC ACID; ESCULETIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 7; NORDIHYDROGUAIARETIC ACID; NSC 741909; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ANTIOXIDANT; CASPASE 8; DUAL SPECIFICITY PHOSPHATASE; DUSP16 PROTEIN, HUMAN; INDOLE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NSC-741909; ONCRASIN 1; ONCRASIN-1; PROTEIN C JUN; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PROTEIN DEPHOSPHORYLATION; CELL PROLIFERATION; CHEMISTRY; CLUSTER ANALYSIS; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVATION; ENZYMOLOGY; IC 50; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTIOXIDANTS; APOPTOSIS; CASPASE 8; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; DRUG SCREENING ASSAYS, ANTITUMOR; DUAL-SPECIFICITY PHOSPHATASES; ENZYME ACTIVATION; HUMANS; INDOLES; INHIBITORY CONCENTRATION 50; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; NORDIHYDROGUAIARETIC ACID; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-JUN; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 77950822385     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-37     Document Type: Article

References (45)

1. Guo W, Wu S, Liu J, Fang B. Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota. Cancer Res 2008, 68:7403-7408. 10.1158/0008-5472.CAN-08-1449, 2678915, 18794128.
2. Wei X, Guo W, Wu S, Wang L, Lu Y, Xu B, Liu J, Fang B. Inhibiting JNK dephosphorylation and induction of apoptosis by a novel anticancer agent NSC-741909 in cancer cells. J Biol Chem 2009, 284:16948-16955. 10.1074/jbc.M109.010256, 19414586.
3. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252. 10.1016/S0092-8674(00)00116-1, 11057897.
4. Jeffrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 2007, 6:391-403. 10.1038/nrd2289, 17473844.
5. Rhee SG, Bae YS, Lee SR, Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Science's STKE [Electronic Resource]: Signal Transduction Knowledge Environment 2000, E1.
6. Meng TC, Fukada T, Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Molecular Cell 2002, 9:387-399. 10.1016/S1097-2765(02)00445-8, 11864611.
7. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661. 10.1016/j.cell.2004.12.041, 15766528.
8. Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y, Piao JH, Yagita H, Okumura K, Doi T, Nakano H. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 2003, 22:3898-3909. 10.1093/emboj/cdg379, 169052, 12881424.
9. Baas AS, Berk BC. Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells. Circ Res 1995, 77:29-36.
10. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130:797-810. 10.1016/j.cell.2007.06.049, 17803904.
11. Choi BM, Pae HO, Jang SI, Kim YM, Chung HT. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 2002, 35:116-126.
12. Shen HM, Liu ZG. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med 2006, 40:928-939. 10.1016/j.freeradbiomed.2005.10.056, 16540388.
13. Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 2007, 96:2181-2196. 10.1002/jps.20874, 17593552.
14. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 1999, 18:7719-7730. 10.1038/sj.onc.1203249, 10618712.
15. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A, Boyd MR. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 1990, 82:1113-1118. 10.1093/jnci/82.13.1113, 2359137.
16. Zhang L, Gu J, Lin T, Huang X, Roth JA, Fang B. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. Gene Ther 2002, 9:1262-1270. 10.1038/sj.gt.3301797, 12215894.
17. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 1999, 11:1-14. 10.1016/S0898-6568(98)00037-0, 10206339.
18. Shimizu T, Numata T, Okada Y. A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl(-) channel. Proc Natl Acad Sci USA 2004, 101:6770-6773. 10.1073/pnas.0401604101, 404120, 15096609.
19. Ling YH, Liebes L, Zou Y, Perez-Soler R. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 2003, 278:33714-33723. 10.1074/jbc.M302559200, 12821677.
20. Gunasekar PG, Borowitz JL, Isom GE. Cyanide-induced generation of oxidative species: involvement of nitric oxide synthase and cyclooxygenase-2. J Pharmacol Exp Ther 1998, 285:236-241.
21. Morris CR, Chen SC, Zhou L, Schopfer LM, Ding X, Mirvish SS. Inhibition by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3. Nutr Cancer 2004, 48:54-63. 10.1207/s15327914nc4801_8, 15203378.
22. Berndt G, Grosser N, Hoogstraate J, Schroder H. AZD3582 increases heme oxygenase-1 expression and antioxidant activity in vascular endothelial and gastric mucosal cells. Eur J Pharm Sci 2005, 25:229-235.
23. Bassenge E, Sommer O, Schwemmer M, Bunger R. Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 2000, 279:H2431-H2438.
24. Guzman-Beltran S, Espada S, Orozco-Ibarra M, Pedraza-Chaverri J, Cuadrado A. Nordihydroguaiaretic acid activates the antioxidant pathway Nrf2/HO-1 and protects cerebellar granule neurons against oxidative stress. Neurosci Lett 2008, 447:167-171. 10.1016/j.neulet.2008.09.079, 18852027.
25. Rillema JA. Effect of NDGA, a lipoxygenase inhibitor, on prolactin actions in mouse mammary gland explants. Prostaglandins Leukot Med 1984, 16:89-94. 10.1016/0262-1746(84)90089-1, 6083569.
26. Shimizu T, Wolfe LS. Arachidonic acid cascade and signal transduction. J Neurochem 1990, 55:1-15. 10.1111/j.1471-4159.1990.tb08813.x, 2113081.
27. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989, 259:315-324. 1138513, 2655580.
28. Bhosle SM, Pandey BN, Huilgol NG, Mishra KP, Bhosle SM, Pandey BN, Huilgol NG, Mishra KP. Membrane oxidative damage and apoptosis in cervical carcinoma cells of patients after radiation therapy. Methods Cell Sci 2002, 24:65-68. 10.1023/A:1024145931652, 12815293.
29. Huang HL, Fang LW, Lu SP, Chou CK, Luh TY, Lai MZ. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 2003, 22:8168-8177. 10.1038/sj.onc.1206979, 14603257.
30. Alexandre J, Hu Y, Lu W, Pelicano H, Huang P. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 2007, 67:3512-3517. 10.1158/0008-5472.CAN-06-3914, 17440056.
31. Furusawa S, Kimura E, Kisara S, Nakano S, Murata R, Tanaka Y, Sakaguchi S, Takayanagi M, Takayanagi Y, Sasaki K. Mechanism of resistance to oxidative stress in doxorubicin resistant cells. Biol Pharm Bull 2001, 24:474-479. 10.1248/bpb.24.474, 11379763.
32. Kotamraju S, Kalivendi SV, Konorev E, Chitambar CR, Joseph J, Kalyanaraman B. Oxidant-induced iron signaling in Doxorubicin-mediated apoptosis. Methods Enzymol 2004, 378:362-382. full_text, 15038980.
33. Ruefli AA, Ausserlechner MJ, Bernhard D, Sutton VR, Tainton KM, Kofler R, Smyth MJ, Johnstone RW. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc Natl Acad Sci USA 2001, 98:10833-10838. 10.1073/pnas.191208598, 58560, 11535817.
34. Simizu S, Takada M, Umezawa K, Imoto M. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 1998, 273:26900-26907. 10.1074/jbc.273.41.26900, 9756937.
35. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997, 275:1649-1652. 10.1126/science.275.5306.1649, 9054359.
36. Maciag A, Anderson LM. Reactive oxygen species and lung tumorigenesis by mutant K-ras: a working hypothesis. Exp Lung Res 2005, 31:83-104. 10.1080/01902140490495048, 15765920.
37. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321. 10.1038/nature01036, 12239572.
38. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, Unterman T, Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008, 14:458-470. 10.1016/j.ccr.2008.11.003, 19061837.
39. Meng D, Shi X, Jiang BH, Fang J. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic Biol Med 2007, 42:1651-1660. 10.1016/j.freeradbiomed.2007.01.037, 17462533.
40. Chen CH, Cheng TH, Lin H, Shih NL, Chen YL, Chen YS, Cheng CF, Lian WS, Meng TC, Chiu WT, Chen JJ. Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol Pharmacol 2006, 69:1347-1355. 10.1124/mol.105.017558, 16391241.
41. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 2002, 277:3101-3108. 10.1074/jbc.M107711200, 11719508.
42. Benhar M, Dalyot I, Engelberg D, Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 2001, 21:6913-6926. 10.1128/MCB.21.20.6913-6926.2001, 99868, 11564875.
43. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001, 81:807-869.
44. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Cancer Res 1998, 74:49-139.
45. Shen HM, Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 2006, 20:1589-1598. 10.1096/fj.05-5603rev, 16873882.